Internal Medicine
Partner With Us
Advertisement
Conexiant chevron_right Internal Medicine chevron_right FDA & Government News

FDA & Government News

thumb description

November 21, 2025

Which Antidepressants Shift Physiology?

Researchers found differences in how antidepressants affect weight, blood pressure, heart rate, and other physiological parameters.

Conexiant

thumb description

November 18, 2025

Plozasiran Wins FDA Nod for FCS

Arrowhead’s small interfering RNA therapy reduced triglycerides and lowered pancreatitis risk in the phase 3 PALISADE trial, providing a quarterly self-administered option for patients with familial chylomicronemia syndrome.

Conexiant

Daily News

Stay up to date with the latest clinical headlines and other information tailored to your specialty.

thumb description

November 13, 2025

‘FDA Said Yes, Despite Inconclusive Evidence’

The FDA’s authorization of the Q-Collar is under scrutiny after researchers identified duplicated data, altered study endpoints, and unsubstantiated “brain protection” claims.

Conexiant

thumb description

November 12, 2025

CDER Taps FDA Veteran as Director 

The HHS and FDA have appointed longtime oncology innovator Richard Pazdur, MD, as director of the Center for Drug Evaluation and Research.

Conexiant

thumb description

November 12, 2025

Longtime FDA Innovator Appointed as Director of CDER

The Department of Health and Human Services and the FDA announced that Richard Pazdur, MD, has been appointed Director of the Center for Drug Evaluation and Research (CDER). Dr. Pazdur is a 26-year ve...

The ASCO Post